SCHEMBL2722101

SCHEMBL2722101

CC(C)CCOc1cccc(C(NC2CCN(C)CC2)c2nc3ccccc3[nH]2)c1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ DRD3 P35462 4/20 0.43
▸ DRD2 P14416 2/20 0.43
▸ HTR1A P08908 1/20 0.39
▸ HTR7 P34969 1/20 0.39
▸ HRH4 Q9H3N8 3/20 0.37
▸ PDE10A Q9Y233 4/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ AR P10275 1/20 0.36
▸ KCNH2 Q12809 1/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ TAAR1 Q96RJ0 1/20 0.35
▸ EHMT2 Q96KQ7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2720626 0.96 DRD3 (0.41) DRD3DRD2HTR1AHTR7HRH4
SCHEMBL2721839 0.92 DRD3 (0.43) DRD3DRD2HTR1AHTR7MEN1
SCHEMBL2720206 0.91 DRD3 (0.39) DRD3DRD2HTR1AHTR7HRH4
SCHEMBL2722268 0.91 DRD3 (0.42) DRD3DRD2HTR1AHTR7HRH4
SCHEMBL2721632 0.90 DRD3 (0.42) DRD3DRD2HTR1AHTR7HRH4
SCHEMBL2720512 0.90 DRD3 (0.42) DRD3DRD2HTR1AHTR7PDE10A
SCHEMBL2720580 0.90 DRD3 (0.41) DRD3DRD2HTR1AHTR7MEN1
SCHEMBL900249 0.89 MAPT (0.42) DRD3DRD2HRH4PDE10AMEN1
SCHEMBL2720427 0.89 DRD3 (0.41) DRD3DRD2HTR1AHTR7HRH4
SCHEMBL2720730 0.89 DRD3 (0.41) DRD3DRD2HTR1AHTR7HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3378476-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS Sensorion (FR) 2018-09-26 — — EP disclosed
US-9688989-B2 H4 receptor inhibitors for treating tinnitus SENSORION (FR) 2017-06-27 — — US disclosed
EP-2621916-B1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET SOC CIV (FR) 2016-02-10 — — EP disclosed
US-20150176010-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS SENSORION (FR) 2015-06-25 — — US disclosed
EP-2447263-A1 Benzazole derivatives as histamine H4 receptor ligands BIOPROJET (FR) 2012-05-02 — — EP disclosed
Send feedback